4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow batefenterol: new trials by email Literature Review of batefenterol trials Research Report on batefenterol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease Batefenterol + Fluticasone Furoate, Placebo, Albuterol - Pulmonary Disease, Chronic Obstructive | Phase 2 | Completed | GlaxoSmithKline | 63 | 2015-12-01 | 2020-07-21 |
| Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD) Batefenterol, Umeclidinium/ Vilanterol, Placebo - Pulmonary Disease, Chronic Obstructive | Phase 2 | Completed | GlaxoSmithKline | 325 | 2015-11-06 | 2019-07-16 |
| A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) GSK961081, Salmeterol, Placebo - Pulmonary Disease, Chronic Obstructive | Phase 2 | Completed | GlaxoSmithKline | 437 | 2010-12-01 | 2016-12-01 |
| A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients GSK961081 - Pulmonary Disease, Chronic Obstructive | Phase 2 | Completed | GlaxoSmithKline | 82 | 2007-06-01 | 2017-02-02 |
Pulmonary Disease, Chronic Obstructive (4)
GlaxoSmithKline (4)
Germany (3) · South Africa (3) · United States (2) · Estonia (1) · Netherlands (1) · Romania (1) · Russia (1) · Slovakia (1) · Sweden (1) · Ukraine (1)
2015 (1)